Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001387008 | SCV001587488 | pathogenic | Fetal akinesia deformation sequence 1; Congenital myasthenic syndrome 11 | 2022-12-07 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1073878). This variant is also known as c.46insC. This premature translational stop signal has been observed in individual(s) with congenital myasthenic syndrome (PMID: 12730725, 14504330). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Leu16Profs*142) in the RAPSN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RAPSN are known to be pathogenic (PMID: 17686188). |
Baylor Genetics | RCV003463017 | SCV004206114 | pathogenic | Fetal akinesia deformation sequence 2 | 2023-11-02 | criteria provided, single submitter | clinical testing | |
OMIM | RCV002280825 | SCV000028723 | pathogenic | Congenital myasthenic syndrome 11 | 2003-01-01 | no assertion criteria provided | literature only |